Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023)
Talphera (TLPH) recorded quarterly Depreciation & Amortization (CF) of $49000.0 in Q2 2023, down 81.3% quarter-over-quarter from $262000.0 in Q1 2023, and down 89.37% on a YoY basis from $461000.0 in Q2 2022.
Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends
Talphera's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $49000.0 for Q2 2023.
- In Q2 2023, Depreciation & Amortization (CF) fell 89.37% year-over-year to $49000.0; the TTM figure through Mar 2024 stood at $49000.0 (down 96.71% YoY), while the FY2023 annual figure was $311000.0, down 81.12% from the prior year.
- Depreciation & Amortization (CF) was $49000.0 for Q2 2023 at Talphera, down from $262000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $579000.0 in Q2 2021 to a low of $49000.0 in Q2 2023.
- Historically, Depreciation & Amortization (CF) has averaged $414000.0 across 5 years, with a median of $437000.0 in 2021.
- The sharpest annual moves came in 2019 and 2023: Depreciation & Amortization (CF) surged 267.86% in 2019, then tumbled 89.37% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $515000.0 in 2019, then declined by 25.83% to $382000.0 in 2020, then rose by 20.68% to $461000.0 in 2021, then declined by 25.81% to $342000.0 in 2022, then sank by 85.67% to $49000.0 in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $49000.0 (Q2 2023), $262000.0 (Q1 2023), and $342000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Dec 31, 2022 | 342,000.00 |
| Dec 31, 2022 | 342,000.00 |
| Sep 30, 2022 | 424,000.00 |
| Sep 30, 2022 | 424,000.00 |
| Jun 30, 2022 | 461,000.00 |
| Jun 30, 2022 | 461,000.00 |
| Mar 31, 2022 | 420,000.00 |
| Mar 31, 2022 | 420,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Sep 30, 2021 | 483,000.00 |
| Sep 30, 2021 | 483,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Mar 31, 2021 | 450,000.00 |